Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human urothelial carcinomas

Yasuhide Kitagawa, Kazuto Kunimi, Hideaki Ito, Hiroshi Sato, Tadao Uchibayashi, Yasunori Okada, Motoharu Seiki, Mikio Namiki

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Purpose: Three different membrane-type matrix metalloproteinases (MT1, 2, 3-MMP) which can activate proMMP-2 (progelatinase A) are thought to have an important role in various human carcinoma invasions and metastases. We examined the mRNA expression of MT-MMPs and the tissue immunolocalization of MT1-MMP in human urothelial carcinomas. Materials and Methods: mRNA was extracted from 27 clinical urothelial carcinomas and 10 normal urothelial mucosa tissues remote from the tumor. RT-PCR using specific primers was performed, and PCR products were hybridized to 32P-labeled internal probes and analyzed by a bioimage analyzer. Immunolocalization was studied using a monoclonal antibody against MT1-MMP (114-6G6). Results: MT1-MMP and MT2-MMP mRNA expressions in urothelial carcinomas were significantly higher than those in the normal mucosa. In contrast, MT3-MMP mRNA was little expressed in both tissues, and the amount of MT3-MMP mRNA appeared to be much lower than MT1-MMP and MT2-MMP in the tissue samples. In terms of the tumor multiplicity, MT1-MMP and MT2-MMP mRNA expressions in the group of multiple tumors were significantly higher than those in the solitary tumor group. The carcinoma cells were immunostained for MT1-MMP predominantly in invasive and superficial carcinoma cells. The immunoreactivity was more intense in the invasive type than in the superficial type. Conclusions: It is suggested that MT1-MMP and MT2-MMP play an important role in the development of human urothelial carcinomas and reflect some aspects of the pathogenesis of multifocal occurrence. In spite of the possible contribution to the invasive and metastatic phenotype, MT1-MMP mRNA and its product are thought to be expressed already in the clinical superficial stage in some cases of this tumor type.

Original languageEnglish
Pages (from-to)1540-1545
Number of pages6
JournalJournal of Urology
Volume160
Issue number4
DOIs
Publication statusPublished - 1998 Oct

Fingerprint

Matrix Metalloproteinase 16
Matrix Metalloproteinase 15
Matrix Metalloproteinase 14
Carcinoma
Messenger RNA
Neoplasms
Matrix Metalloproteinases
Mucous Membrane
Polymerase Chain Reaction
Human Development
Monoclonal Antibodies

Keywords

  • Membrane-type matrix metalloproteinase
  • Urothelial carcinoma

ASJC Scopus subject areas

  • Urology

Cite this

Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human urothelial carcinomas. / Kitagawa, Yasuhide; Kunimi, Kazuto; Ito, Hideaki; Sato, Hiroshi; Uchibayashi, Tadao; Okada, Yasunori; Seiki, Motoharu; Namiki, Mikio.

In: Journal of Urology, Vol. 160, No. 4, 10.1998, p. 1540-1545.

Research output: Contribution to journalArticle

Kitagawa, Y, Kunimi, K, Ito, H, Sato, H, Uchibayashi, T, Okada, Y, Seiki, M & Namiki, M 1998, 'Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human urothelial carcinomas', Journal of Urology, vol. 160, no. 4, pp. 1540-1545. https://doi.org/10.1016/S0022-5347(01)62609-0
Kitagawa, Yasuhide ; Kunimi, Kazuto ; Ito, Hideaki ; Sato, Hiroshi ; Uchibayashi, Tadao ; Okada, Yasunori ; Seiki, Motoharu ; Namiki, Mikio. / Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human urothelial carcinomas. In: Journal of Urology. 1998 ; Vol. 160, No. 4. pp. 1540-1545.
@article{d2c99e5e6db04e91a780b76715e5722e,
title = "Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human urothelial carcinomas",
abstract = "Purpose: Three different membrane-type matrix metalloproteinases (MT1, 2, 3-MMP) which can activate proMMP-2 (progelatinase A) are thought to have an important role in various human carcinoma invasions and metastases. We examined the mRNA expression of MT-MMPs and the tissue immunolocalization of MT1-MMP in human urothelial carcinomas. Materials and Methods: mRNA was extracted from 27 clinical urothelial carcinomas and 10 normal urothelial mucosa tissues remote from the tumor. RT-PCR using specific primers was performed, and PCR products were hybridized to 32P-labeled internal probes and analyzed by a bioimage analyzer. Immunolocalization was studied using a monoclonal antibody against MT1-MMP (114-6G6). Results: MT1-MMP and MT2-MMP mRNA expressions in urothelial carcinomas were significantly higher than those in the normal mucosa. In contrast, MT3-MMP mRNA was little expressed in both tissues, and the amount of MT3-MMP mRNA appeared to be much lower than MT1-MMP and MT2-MMP in the tissue samples. In terms of the tumor multiplicity, MT1-MMP and MT2-MMP mRNA expressions in the group of multiple tumors were significantly higher than those in the solitary tumor group. The carcinoma cells were immunostained for MT1-MMP predominantly in invasive and superficial carcinoma cells. The immunoreactivity was more intense in the invasive type than in the superficial type. Conclusions: It is suggested that MT1-MMP and MT2-MMP play an important role in the development of human urothelial carcinomas and reflect some aspects of the pathogenesis of multifocal occurrence. In spite of the possible contribution to the invasive and metastatic phenotype, MT1-MMP mRNA and its product are thought to be expressed already in the clinical superficial stage in some cases of this tumor type.",
keywords = "Membrane-type matrix metalloproteinase, Urothelial carcinoma",
author = "Yasuhide Kitagawa and Kazuto Kunimi and Hideaki Ito and Hiroshi Sato and Tadao Uchibayashi and Yasunori Okada and Motoharu Seiki and Mikio Namiki",
year = "1998",
month = "10",
doi = "10.1016/S0022-5347(01)62609-0",
language = "English",
volume = "160",
pages = "1540--1545",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human urothelial carcinomas

AU - Kitagawa, Yasuhide

AU - Kunimi, Kazuto

AU - Ito, Hideaki

AU - Sato, Hiroshi

AU - Uchibayashi, Tadao

AU - Okada, Yasunori

AU - Seiki, Motoharu

AU - Namiki, Mikio

PY - 1998/10

Y1 - 1998/10

N2 - Purpose: Three different membrane-type matrix metalloproteinases (MT1, 2, 3-MMP) which can activate proMMP-2 (progelatinase A) are thought to have an important role in various human carcinoma invasions and metastases. We examined the mRNA expression of MT-MMPs and the tissue immunolocalization of MT1-MMP in human urothelial carcinomas. Materials and Methods: mRNA was extracted from 27 clinical urothelial carcinomas and 10 normal urothelial mucosa tissues remote from the tumor. RT-PCR using specific primers was performed, and PCR products were hybridized to 32P-labeled internal probes and analyzed by a bioimage analyzer. Immunolocalization was studied using a monoclonal antibody against MT1-MMP (114-6G6). Results: MT1-MMP and MT2-MMP mRNA expressions in urothelial carcinomas were significantly higher than those in the normal mucosa. In contrast, MT3-MMP mRNA was little expressed in both tissues, and the amount of MT3-MMP mRNA appeared to be much lower than MT1-MMP and MT2-MMP in the tissue samples. In terms of the tumor multiplicity, MT1-MMP and MT2-MMP mRNA expressions in the group of multiple tumors were significantly higher than those in the solitary tumor group. The carcinoma cells were immunostained for MT1-MMP predominantly in invasive and superficial carcinoma cells. The immunoreactivity was more intense in the invasive type than in the superficial type. Conclusions: It is suggested that MT1-MMP and MT2-MMP play an important role in the development of human urothelial carcinomas and reflect some aspects of the pathogenesis of multifocal occurrence. In spite of the possible contribution to the invasive and metastatic phenotype, MT1-MMP mRNA and its product are thought to be expressed already in the clinical superficial stage in some cases of this tumor type.

AB - Purpose: Three different membrane-type matrix metalloproteinases (MT1, 2, 3-MMP) which can activate proMMP-2 (progelatinase A) are thought to have an important role in various human carcinoma invasions and metastases. We examined the mRNA expression of MT-MMPs and the tissue immunolocalization of MT1-MMP in human urothelial carcinomas. Materials and Methods: mRNA was extracted from 27 clinical urothelial carcinomas and 10 normal urothelial mucosa tissues remote from the tumor. RT-PCR using specific primers was performed, and PCR products were hybridized to 32P-labeled internal probes and analyzed by a bioimage analyzer. Immunolocalization was studied using a monoclonal antibody against MT1-MMP (114-6G6). Results: MT1-MMP and MT2-MMP mRNA expressions in urothelial carcinomas were significantly higher than those in the normal mucosa. In contrast, MT3-MMP mRNA was little expressed in both tissues, and the amount of MT3-MMP mRNA appeared to be much lower than MT1-MMP and MT2-MMP in the tissue samples. In terms of the tumor multiplicity, MT1-MMP and MT2-MMP mRNA expressions in the group of multiple tumors were significantly higher than those in the solitary tumor group. The carcinoma cells were immunostained for MT1-MMP predominantly in invasive and superficial carcinoma cells. The immunoreactivity was more intense in the invasive type than in the superficial type. Conclusions: It is suggested that MT1-MMP and MT2-MMP play an important role in the development of human urothelial carcinomas and reflect some aspects of the pathogenesis of multifocal occurrence. In spite of the possible contribution to the invasive and metastatic phenotype, MT1-MMP mRNA and its product are thought to be expressed already in the clinical superficial stage in some cases of this tumor type.

KW - Membrane-type matrix metalloproteinase

KW - Urothelial carcinoma

UR - http://www.scopus.com/inward/record.url?scp=0032322527&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032322527&partnerID=8YFLogxK

U2 - 10.1016/S0022-5347(01)62609-0

DO - 10.1016/S0022-5347(01)62609-0

M3 - Article

C2 - 9751409

AN - SCOPUS:0032322527

VL - 160

SP - 1540

EP - 1545

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 4

ER -